Cabergoline
NDC 70512-860, cabergoline, tablet, from SOLA Pharmaceuticals, LLC.
- Product NDC
- 70512-860
- Status
- Listed
- Labeler
- SOLA Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076310
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70512-860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CABERGOLINE.5 mg/1
Pharmacologic classes
Ergolines [CS]; Ergot Derivative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70512-860-08 | 70512086008 | 8 TABLET in 1 BOTTLE (70512-860-08) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/275a6a25-c3c9-4258-a610-0b00752517f7NADAC price for package 70512086008
GET /v1/drugs/nadac/70512086008
Use it
Look up 70512-860 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70512-860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70512-860. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.